Oklahoma 2022 2022 Regular Session

Oklahoma Senate Bill SB1275 Introduced / Bill

Filed 01/13/2022

                     
 
 
Req. No. 2962 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
2nd Session of the 58th Legislature (2022) 
 
SENATE BILL 1275 	By: Howard 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to opioid abatement; amending 74 O.S. 
2021, Sections 30.5 and 30.8, which relate to the 
Political Subdivisions Opioid Ab atement Grants Act; 
modifying scope of certain defined terms; deleting 
definition; revising criteria for allocatin g opioid 
grant awards to eligible participants ; providing for 
the reimbursement of attorney fees and expenses 
associated with legal services agreements; requiring 
initial opioid grant awards to be listed on a 
distribution table; updating statutory language; and 
declaring an emergency . 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY    74 O.S. 2021, Section 30.5, is 
amended to read as follows: 
Section 30.5. As used in the Political S ubdivisions Opioid 
Abatement Grants Act: 
1.  “Approved purpose” and “approved purposes” mean evidence-
based, forward-looking strategies, programming and se rvices used to: 
a. expand the availability of treatment for individuals 
affected by opioid use diso rders, co-occurring 
substance use disorders and mental health issues,   
 
 
Req. No. 2962 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
b. develop, promote and provide evidence-based opioid use 
prevention strategies, 
c. provide opioid use disorder and co -occurring substance 
use disorder avoidance and awareness educatio n, 
d. decrease the oversupply of licit and illicit opioids, 
e. support recovery from ad diction services performed by 
qualified and approp riately licensed provi ders, 
f. treat opioid use, abuse and disorders , including early 
intervention screening, counse ling and support, 
g. support individuals in treatment and recovery from 
opioid use, abuse and disorder, 
h. provide programs or services to c onnect individuals 
with opioid use, abuse or disorder, or who are at risk 
of developing opioid use disorder, co -occurring 
substance use disorder and mental health issues, with 
treatment and counseling pr ograms and services, 
i. address the needs of individu als who are involved, or 
who are at risk of becoming involved, in the criminal 
justice system due to opioid use, abuse or disorder 
through programs or services in municipal and county 
criminal judicial systems, including prearrest and 
postarrest diversion programs, pretrial ser vices and 
drug or recovery courts,   
 
 
Req. No. 2962 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
j. address the needs of pregnant or parenting women wit h 
opioid use, abuse or disorder and their families , 
including babies with neonatal abstin ence syndrome, 
k. address the needs of parents and care givers caring for 
babies with neonatal abstinence syndrome, 
l. support efforts to prevent overprescribing and ensure 
appropriate prescribing and dispensing of opioids, 
l. m. support efforts to disco urage or prevent misu se of 
opioids, including the oversupp ly of licit and illici t 
opioids, 
m. n. support efforts to prevent or reduce overdose deaths 
or other opioid-related harms, including through 
increased availability and distribution of naloxone 
and other drugs that treat overdoses for use by first 
responders, persons who have ex perienced an overdose 
event, families, schools, community -based service 
providers, social workers and other members of the 
public, 
n. o. reimburse or fund law enforcement and emergency 
responder expenditures relating to the opioid 
epidemic, including costs of responding to emergency 
medical or police calls for service, equipment, 
treatment or response alternatives, mental health 
response training and training for law enforceme nt and   
 
 
Req. No. 2962 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
emergency responders as to appropriate practices and 
precautions when deali ng with opioids or individuals 
who are at risk of opioid overdose or death, 
o. p. reimburse attorney fees and expenses directly related 
to opioid litigation incurred as part of legal 
services agreements entered into before May 21, 202 0, 
q. support efforts to provide leadership, planning and 
coordination to abate the opioid epidemic throu gh 
activities, programs or strategies for prevention and 
recovery models, including regional intergovernmental 
efforts and not-for-profit agency suppor t, 
p. r. support education of youths regarding the dangers of 
opioid use, abuse and addiction, 
q. s. fund training relative to any approved purpose, 
r. t. monitor, surveil and evaluate opioid use, abuse or 
disorder, or 
s. u. provide opioid abatement as ide ntified by the Oklahom a 
Opioid Abatement Board as consistent with the purpose 
of this act the Political Subdivisions Opioid 
Abatement Grants Act . 
Provided that, such strategies, programming and services occurred on 
or after January 1, 2006 2015; 
2.  “Board” means the Oklahoma O pioid Abatement Board;   
 
 
Req. No. 2962 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
3.  “Eligible participant ” means any political subdiv ision or 
first responder organization that obtained legal representati on or 
participated in litigation with pharmaceutica l supply chain 
participants prior to the effective date of this act negatively 
impacted by the opioid crisis ; 
4.  “First responder organization” means a nonprofit 
organization formed and in good standing under 501(c)(9) of the 
Internal Revenue Code, whose primary function is to benefit public 
safety employees; 
5.  “Nonapproved purpose” and “nonapproved purposes ” mean 
strategies, programming and services not falling within the 
definition of “approved purpose” or “approved purposes” as defined 
in this act section; 
6. 5.  “Opioid funds” means all monetary amounts obta ined 
through a settlement or judgment by the Attorney General on behalf 
of the State of Oklahoma this state related to opioid litigation 
involving pharmaceutical supply chai n participants, including the 
Purdue Political Subdivisions Fund but exc luding all other funds 
received pursuant to the Purdue Settlement Agreement; 
7. 6.  “Opioid grant awards” means grants funded from the 
Oklahoma Opioid Abatement Revolving Fund, awarde d pursuant to the 
provisions of this act the Political Subdivisions Opioi d Abatement 
Grants Act;   
 
 
Req. No. 2962 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
8. 7.  “Pharmaceutical supply chain ” means the process and 
channels through which controlled substances are manufactured, 
marketed, promoted, distributed or d ispensed; 
9. 8.  “Pharmaceutical supply chain participant ” means any 
entity that engages in or has engaged in the manufacture, marketing, 
promotion, distribution or d ispensing of an opioid analgesic; 
10. 9.  “Political subdivision ” and “political subdivisions” 
have the same meaning as provi ded in subparagraphs a, b, c and d of 
paragraph 11 of Section 152 of Title 51 of the Oklahoma Statutes; 
11. 10.  “Purdue Political Subdivision Fund” means the Twelve 
Million Five Hundred Thousand Dollars ($12,500,000.0 0) plus any 
interest accrued thereon r eceived from the Revive Oklahoma Health 
Foundation consisting of funds from the Purdue Settlement Agreement 
designed for distribu tion to political subdivisions which have 
executed a release of legal claims as required by the Purdue 
Settlement Agreement; an d 
12. 11.  “Purdue Settlement Agreement ” means the settlement 
agreement entered into by the State of Oklahoma this state and 
Purdue Pharma L.P., Purdue Pharma, Inc. and the Purdue Frederick 
Company on March 26, 2019, and approve d by the Court on April 2, 
2019. 
SECTION 2.     AMENDATORY    74 O.S. 2021, Section 30.8, is 
amended to read as follows:   
 
 
Req. No. 2962 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Section 30.8. A.  1.  The Oklahoma Opioid Abatement Board shall 
conduct an initial disbursement of opioid grant awards to 
participating eligibl e participants.  Such opioid grant awards shall 
be allocated amongst the different participati ng eligible 
participants based on the following criteria, giving equal weight to 
each criteria: 
a. the number of people per capita suffering from opioid 
use disorder in the participating political 
subdivision, or in the absence of such information, 
the opioid prescription rate in the political 
subdivision compared to the national average opio id 
prescription rate, 
b. the number of opioid overdose deaths in the 
participating political subdivision, and 
c. the amount of opioids distributed within the 
participating political subdivision adopted by the 
Board. 
2.  Grant awards shall be subject to legal services agreements 
entered into by participating eligible participants based on the 
grant awards. Attorney fees and exp enses associated with legal 
services agreements may be reimbursed as an approved purpose in 
addition to grants awarded . 
3. Initial opioid grant awards as provided for in this 
subsection shall be listed in an opioid grant award allocation   
 
 
Req. No. 2962 	Page 8  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
matrix distribution table reviewed and approved by the B oard to 
ensure that such awards adhere to the criteria as provided in this 
subsection adopted by the Board. 
B.  Following the awarding of opioid grant awards pursuant to 
subsection A of this section, any remaining une ncumbered balance in 
the Oklahoma Opioid Abatement Revolving Fund shall be available to 
the Board to award as grants to eligibl e participants; provided such 
awards shall only be utilized by eligible partici pants for approved 
purposes. 
C.  In the event an e ligible participant merges, dissolves or 
ceases to exist, any remaining allocations of an awarded opioid 
grant award in excess of Five Hundred Dollars ($500.00) shall be 
reallocated equitably based on the c omposition of the successor 
eligible participant o r the successor eligible participants . 
SECTION 3.  It being immediately necessary for the preservation 
of the public peace, health or safety, an emergency is hereby 
declared to exist, by rea son whereof this act shall take effect and 
be in full force from and after its passage and approval. 
 
58-2-2962 DC 1/13/2022 4:39:49 PM